Press Releases

Amniox Medical Enters into Agreement with Intalere

ATLANTA, GA – June 8, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane for wound healing and soft-tissue repair. Intalere is a professional supply chain company offering a […]


New Clinical Evidence Continues to Support the Effectiveness and Value of Amniox Medical Products

Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound Allograft – Amniox’s proprietary cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) product for chronic wound […]


Amniox Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines

Expanded Access to Industry-Leading Technology for 10.2 Million Military Personnel ATLANTA, GA – April 17, 2017 — Amniox Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its NEOX and CLARIX product lines. The agreement provides the Military Health System broad access to NEOX Wound Allograft – indicated for use […]


Amniox Highlights Three Studies Demonstrating Effectiveness of Umbilical Cord Tissue for Treating Chronic Wounds

Studies Document Healing Rates of 78% – 87% ATLANTA, GA – April 7, 2017 — Amniox Medical, Inc., a TissueTech, Inc. company, highlighted the publication of three studies concerning NEOX CORD 1K, its cryopreserved human umbilical cord tissue. In contrast to competitive offerings, these studies document the consistent effectiveness of the Company’s proprietary technology in […]


AMNIOX Study Confirms Benefits of CLARIX FLO for Plantar Fasciitis

ATLANTA – March 30, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today the results of a study demonstrating the application of its unique cryopreserved human umbilical cord tissue for the treatment of patients with plantar fasciitis. The findings were recently presented at the American College of Foot and Ankle Surgeons in Las Vegas. In this study, forty-three […]


AMNIOX Highlights Study Demonstrating Improved Outcomes in Patients Treated with CLARIX® Regenerative Matrix as an Adjunct to Lumbar Discectomy

ATLANTA – October 26, 2016 – AMNIOX Medical, Inc., a TissueTech™, Inc., company, announced the results of a prospective randomized clinical study of its proprietary cryopreserved Amniotic Membrane (AM) as an adjunct to lumbar discectomy. The findings will be presented at the North American Spine Society 2016 Annual Meeting, by the study’s lead investigator, D. Greg Anderson, M.D. of the […]


TissueTech Highlights Clinical Experience Showing In-Utero Spina Bifida Repair with NEOX® Wound Allograft

ATLANTA – July 26, 2016 – TissueTech Inc., announced the publication of initial clinical experience with inutero spina bifida repair using NEOX cryopreserved umbilical cord allograft marketed by Amniox Medical Inc., a TissueTech company. The data were published in Obstetrics & Gynecology by Dr. Ramesha Papanna of UTHealth McGovern Medical School and the Fetal Center at Children’s Memorial Hermann Hospital, […]


AMNIOX Highlights Studies Finding CLARIX® FLO and CLARIX® CORD 1K Improving Foot and Ankle Outcomes

ATLANTA – July 25, 2016 – AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the results of two studies presented at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting. Dr. David Garras of Midwest Orthopaedic Consultants, an assistant professor at the University of Illinois at Chicago, and Dr. Ryan Scott, of the CORE Institute in Phoenix, presented Plantar […]


New Evidence Highlights Effectiveness and Value of AMNIOX Medical Products

ATLANTA – April 14, 2016 – AMNIOX Medical, Inc., a TissueTech™, Inc., company, announced today that eight clinical posters demonstrating the effectiveness of NEOX® Wound Allograft – Amniox’s proprietary cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) product for chronic wound management – will be presented at this week’s Symposium on Advanced Wound Care (SAWC) and Wound Healing Society Meeting. The meeting […]


Amniox Medical’s NEOX CORD 1K is the First Cryopreserved Umbilical Cord Allograft that Can Be Safely Refrigerated for Two Years

ATLANTA – April 13, 2016 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced at the Spring Symposium on Advanced Wound Care in Atlanta that the company’s proprietary CryoTek® Cool Storage Technology now delivers the first cryopreserved umbilical cord allograft that can be safely refrigerated for as long as two years without compromising the structural or functional integrity of the tissue. […]